Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2003, p. 2012-2014, Vol. 47, No. 6
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.6.2012-2014.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Omrane Belhadj,2 and Lluis M. Mir1*
Laboratoire Vectorologie et Transfert de Gènes, UMR 8121 CNRS, Institut Gustave-Roussy, 94805 Villejuif Cédex, France,1 Laboratoire de Biochimie et Technobiologie, Faculté des Sciences de Tunis, Campus Universitaire, 1060 Tunis, Tunisia2
Received 2 December 2002/ Accepted 5 March 2003
|
|
|---|
|
|
|---|
36) (15). Yeast cells were grown to a density of approximately 108 cells/ml through shaking and aeration in complete YPD (yeast extract-peptane-dextrose) medium (13) at 30°C. We determined the percentage of reversibly permeabilized cells by the lucifer yellow test (6) and prepared spheroplasts as described previously (2) with lyticase from Sigma. A total of 5 x 107 cells were electropermeabilized as described previously (1) in the absence of dithiothreitol by using eight 100-µs square-wave pulses at a frequency of 1 Hz. Spheroplasts were electroporated in 1.2 M sorbitol-1 mM MgCl2-10 mM Tris-HCl (pH 7.5). No effect on survival was detected when electric fields from 0 to 2,000 V/cm were applied to either the cells or the spheroplasts. Optimal conditions were chosen such that the electric field resulted in 70 to 75% survival and electropermeabilization of approximately 85% of those surviving cells (i.e., 4,640 and 3,920 V/cm for FY67 and YPH-1 cells, respectively, and 4,300 and 3,900 V/cm for FY67 and YPH-1 spheroplasts, respectively) (Fig. 1). Our results show that the optimal permeabilization value is a function of the difference between the mean cell diameter for the two strains, as determined by flow cytometry (50.5 ± 2.12 and 58 ± 2.83, in arbitrary units, for FY67 and YPH-1 cells, respectively, and 49 ± 2.15 and 56.5 ± 1.41 for FY67 and YPH-1 spheroplasts, respectively). Our data also show that the removal of the cell wall does not significantly alter the cell diameter and has almost no influence on the optimal electrical field strength applied to the spheroplasts. Thus, the presence of the cell wall does not affect the electropermeabilization of the plasma membrane.
![]() View larger version (30K): [in a new window] |
FIG. 1. Influence of electric field strength on yeast cell (A) or spheroplast (B) permeabilization and survival. Each point represents the mean of three independent experiments performed in triplicate. Bars represent standard errors of the means. LY, lucifer yellow.
|
![]() View larger version (28K): [in a new window] |
FIG. 2. BLM survival response curves for FY67 and YPH-1 cells (A) or spheroplasts (B) exposed or not exposed to permeabilizing electric pulses. Each point represents the mean of three independent experiments performed in triplicate. Bars represent standard errors of the means.
|
|
View this table: [in a new window] |
TABLE 1. Contributions of the cell wall and the plasma membrane in limiting the cytotoxicity of BLM for yeast cells and spheroplastsa
|
Electroporation of spheroplasts increased the cytotoxicity of BLM 17-fold for FY67 spheroplasts and 667-fold for YPH-1 spheroplasts (Table 1). Unexpectedly, when electropermeabilization was used, electroporated YPH-1 spheroplasts were eight times less resistant to BLM than FY67 spheroplasts (Fig. 2B and Table 1). Thus, in the absence of the cell wall, the actual levels of BLM uptake and cytotoxicity were 40 times (8 x 5) higher for the YPH-1 strain than for the FY67 strain. We have previously demonstrated the presence of a BLM-binding protein (BBP) that plays a role in the internalization and cytotoxicity of BLM in mammalian cells (11, 12). The procedure previously implemented to prepare this mammalian plasma membrane protein was repeated with yeast spheroplasts (11). As a result of the studies with the 57Co-BLM complex (9), we report here for the first time the detection of a BBP of approximately 250 kDa in the membrane extracts of yeast cells (Fig. 3). Quantification of the 57Co-BLM-BBP complex indicates that the intensity of the radioactive band was approximately seven times lower for the YPH-1 strain extract than for the FY67 strain extract (results not shown). Assuming that this protein is involved in the uptake and cytotoxicity of BLM in yeast cells like it is in animal cells (12), the 7-fold increase in BBP could explain the 40-fold difference in resistance between YPH-1 and FY67 spheroplasts. Indeed, in animal cells a 3-fold increase in the level of BBP was found to cause a 22-fold increase in cell sensitivity to BLM (12).
![]() View larger version (64K): [in a new window] |
FIG. 3. Visualization of the BBPs in crude yeast membrane extracts. Reported molecular weights correspond to the high-molecular-weight-range color markers (molecular weights, 29,000 to 205,000; Sigma) that migrated in parallel. The arrow indicates the position of the radioactive BBP band detected at about 250 kDa.
|
40-fold (150/3.4 = 44.1) decrease in BLM uptake in the presence of the cell wall, similar to the decrease calculated for the spheroplasts. These results suggest that both barriers act independently. In conclusion, this work demonstrates that both the cell wall and the cell membrane limit the uptake of small hydrophilic molecules (e.g., BLM) by yeast cells. The restrictions imposed by the cell wall and the plasma membrane are independent of each other but are cell type dependent. We also demonstrate that cell electropermeabilization is an interesting method that can be used to increase the levels of uptake of small hydrophilic molecules in yeast.
This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut Gustave-Roussy, the Association pour la Recherche contre le Cancer, and the Ministère de l'Enseignement Supérieur de Tunisie. We thank the CNRS (France) and DGRST (Tunisia) for travel support to M.A., O.T., and L.M.M. for scientific exchanges. L.M.M. also acknowledges the support of the EU commission (grant QLK3-1999-00484).
Present address: The Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, QC H3T 1E2, Canada. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»